New indications for anti-IL-I-beta therapy

Details for Australian Patent Application No. 2012203932 (hide)

Owner Novartis AG

Inventors Gram, Hermann; Jung, Thomas

Agent Davies Collison Cave

Pub. Number AU-A-2012203932

Parent 2008257520

Filing date 5 July 2012

Wipo publication date 26 July 2012

International Classifications

C07K 14/545 Peptides having more than 20 amino acids

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 37/06 Drugs for immunological or allergic disorders

C07K 16/24 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

19 July 2012 Complete Application Filed

26 July 2012 Application Open to Public Inspection

  Published as AU-A-2012203932

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012203933-Improved Packer

2012203931-New indications for anti-IL-I-beta therapy